The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Lumbosacral Radicular Pain Management Market Research Report 2024
Synopsis
Lumbosacral radicular pain is a type of pain that originates from the lower back and radiates down the leg, typically caused by compression or irritation of the spinal nerves. The management of lumbosacral radicular pain typically involves a combination of pharmacological and non-pharmacological interventions.
Global Lumbosacral Radicular Pain Management market is projected to reach US$ 1098.4 million in 2029, increasing from US$ 794 million in 2022, with the CAGR of 5.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Lumbosacral Radicular Pain Management market research.
The lumbosacral radicular pain management market is primarily driven by the increasing prevalence of conditions such as herniated discs and spinal stenosis, which often lead to lumbosacral radicular pain (sciatica). As the global population ages and sedentary lifestyles become more common, the incidence of these spinal disorders rises, fueling the demand for effective pain management options. Additionally, advancements in diagnostic imaging and pain intervention techniques, such as epidural steroid injections and minimally invasive surgeries, drive the market's growth by enabling accurate diagnosis and targeted treatments. However, the market also faces challenges, including the complexity of lumbosacral radicular pain cases and the variability of patient responses to different treatments. Developing personalized and comprehensive pain management plans can be challenging, as the underlying causes and mechanisms of lumbosacral radicular pain can vary among individuals. Moreover, the need for safe and effective long-term pain relief options without adverse effects poses a hurdle in the field.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Lumbosacral Radicular Pain Management market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Semnur Pharmaceuticals
Eliem Therapeutics
Medtronic Spinal and Biologics
Teva Pharmaceutical
3M Company
Ultradent Products
Nobel Biocare Holdings
Eli Lilly and Company
Segment by Type
Oral
Topical
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies and Drug Stores
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Lumbosacral Radicular Pain Management report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Lumbosacral radicular pain is a type of pain that originates from the lower back and radiates down the leg, typically caused by compression or irritation of the spinal nerves. The management of lumbosacral radicular pain typically involves a combination of pharmacological and non-pharmacological interventions.
Global Lumbosacral Radicular Pain Management market is projected to reach US$ 1098.4 million in 2029, increasing from US$ 794 million in 2022, with the CAGR of 5.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Lumbosacral Radicular Pain Management market research.
The lumbosacral radicular pain management market is primarily driven by the increasing prevalence of conditions such as herniated discs and spinal stenosis, which often lead to lumbosacral radicular pain (sciatica). As the global population ages and sedentary lifestyles become more common, the incidence of these spinal disorders rises, fueling the demand for effective pain management options. Additionally, advancements in diagnostic imaging and pain intervention techniques, such as epidural steroid injections and minimally invasive surgeries, drive the market's growth by enabling accurate diagnosis and targeted treatments. However, the market also faces challenges, including the complexity of lumbosacral radicular pain cases and the variability of patient responses to different treatments. Developing personalized and comprehensive pain management plans can be challenging, as the underlying causes and mechanisms of lumbosacral radicular pain can vary among individuals. Moreover, the need for safe and effective long-term pain relief options without adverse effects poses a hurdle in the field.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Lumbosacral Radicular Pain Management market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Semnur Pharmaceuticals
Eliem Therapeutics
Medtronic Spinal and Biologics
Teva Pharmaceutical
3M Company
Ultradent Products
Nobel Biocare Holdings
Eli Lilly and Company
Segment by Type
Oral
Topical
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies and Drug Stores
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Lumbosacral Radicular Pain Management report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lumbosacral Radicular Pain Management Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Topical
1.3 Market by Application
1.3.1 Global Lumbosacral Radicular Pain Management Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies and Drug Stores
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lumbosacral Radicular Pain Management Market Perspective (2018-2029)
2.2 Lumbosacral Radicular Pain Management Growth Trends by Region
2.2.1 Global Lumbosacral Radicular Pain Management Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Lumbosacral Radicular Pain Management Historic Market Size by Region (2018-2023)
2.2.3 Lumbosacral Radicular Pain Management Forecasted Market Size by Region (2024-2029)
2.3 Lumbosacral Radicular Pain Management Market Dynamics
2.3.1 Lumbosacral Radicular Pain Management Industry Trends
2.3.2 Lumbosacral Radicular Pain Management Market Drivers
2.3.3 Lumbosacral Radicular Pain Management Market Challenges
2.3.4 Lumbosacral Radicular Pain Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lumbosacral Radicular Pain Management Players by Revenue
3.1.1 Global Top Lumbosacral Radicular Pain Management Players by Revenue (2018-2023)
3.1.2 Global Lumbosacral Radicular Pain Management Revenue Market Share by Players (2018-2023)
3.2 Global Lumbosacral Radicular Pain Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lumbosacral Radicular Pain Management Revenue
3.4 Global Lumbosacral Radicular Pain Management Market Concentration Ratio
3.4.1 Global Lumbosacral Radicular Pain Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lumbosacral Radicular Pain Management Revenue in 2022
3.5 Lumbosacral Radicular Pain Management Key Players Head office and Area Served
3.6 Key Players Lumbosacral Radicular Pain Management Product Solution and Service
3.7 Date of Enter into Lumbosacral Radicular Pain Management Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lumbosacral Radicular Pain Management Breakdown Data by Type
4.1 Global Lumbosacral Radicular Pain Management Historic Market Size by Type (2018-2023)
4.2 Global Lumbosacral Radicular Pain Management Forecasted Market Size by Type (2024-2029)
5 Lumbosacral Radicular Pain Management Breakdown Data by Application
5.1 Global Lumbosacral Radicular Pain Management Historic Market Size by Application (2018-2023)
5.2 Global Lumbosacral Radicular Pain Management Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Lumbosacral Radicular Pain Management Market Size (2018-2029)
6.2 North America Lumbosacral Radicular Pain Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Lumbosacral Radicular Pain Management Market Size by Country (2018-2023)
6.4 North America Lumbosacral Radicular Pain Management Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lumbosacral Radicular Pain Management Market Size (2018-2029)
7.2 Europe Lumbosacral Radicular Pain Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Lumbosacral Radicular Pain Management Market Size by Country (2018-2023)
7.4 Europe Lumbosacral Radicular Pain Management Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lumbosacral Radicular Pain Management Market Size (2018-2029)
8.2 Asia-Pacific Lumbosacral Radicular Pain Management Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Lumbosacral Radicular Pain Management Market Size by Region (2018-2023)
8.4 Asia-Pacific Lumbosacral Radicular Pain Management Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lumbosacral Radicular Pain Management Market Size (2018-2029)
9.2 Latin America Lumbosacral Radicular Pain Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Lumbosacral Radicular Pain Management Market Size by Country (2018-2023)
9.4 Latin America Lumbosacral Radicular Pain Management Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lumbosacral Radicular Pain Management Market Size (2018-2029)
10.2 Middle East & Africa Lumbosacral Radicular Pain Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Lumbosacral Radicular Pain Management Market Size by Country (2018-2023)
10.4 Middle East & Africa Lumbosacral Radicular Pain Management Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Semnur Pharmaceuticals
11.1.1 Semnur Pharmaceuticals Company Detail
11.1.2 Semnur Pharmaceuticals Business Overview
11.1.3 Semnur Pharmaceuticals Lumbosacral Radicular Pain Management Introduction
11.1.4 Semnur Pharmaceuticals Revenue in Lumbosacral Radicular Pain Management Business (2018-2023)
11.1.5 Semnur Pharmaceuticals Recent Development
11.2 Eliem Therapeutics
11.2.1 Eliem Therapeutics Company Detail
11.2.2 Eliem Therapeutics Business Overview
11.2.3 Eliem Therapeutics Lumbosacral Radicular Pain Management Introduction
11.2.4 Eliem Therapeutics Revenue in Lumbosacral Radicular Pain Management Business (2018-2023)
11.2.5 Eliem Therapeutics Recent Development
11.3 Medtronic Spinal and Biologics
11.3.1 Medtronic Spinal and Biologics Company Detail
11.3.2 Medtronic Spinal and Biologics Business Overview
11.3.3 Medtronic Spinal and Biologics Lumbosacral Radicular Pain Management Introduction
11.3.4 Medtronic Spinal and Biologics Revenue in Lumbosacral Radicular Pain Management Business (2018-2023)
11.3.5 Medtronic Spinal and Biologics Recent Development
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Detail
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Lumbosacral Radicular Pain Management Introduction
11.4.4 Teva Pharmaceutical Revenue in Lumbosacral Radicular Pain Management Business (2018-2023)
11.4.5 Teva Pharmaceutical Recent Development
11.5 3M Company
11.5.1 3M Company Company Detail
11.5.2 3M Company Business Overview
11.5.3 3M Company Lumbosacral Radicular Pain Management Introduction
11.5.4 3M Company Revenue in Lumbosacral Radicular Pain Management Business (2018-2023)
11.5.5 3M Company Recent Development
11.6 Ultradent Products
11.6.1 Ultradent Products Company Detail
11.6.2 Ultradent Products Business Overview
11.6.3 Ultradent Products Lumbosacral Radicular Pain Management Introduction
11.6.4 Ultradent Products Revenue in Lumbosacral Radicular Pain Management Business (2018-2023)
11.6.5 Ultradent Products Recent Development
11.7 Nobel Biocare Holdings
11.7.1 Nobel Biocare Holdings Company Detail
11.7.2 Nobel Biocare Holdings Business Overview
11.7.3 Nobel Biocare Holdings Lumbosacral Radicular Pain Management Introduction
11.7.4 Nobel Biocare Holdings Revenue in Lumbosacral Radicular Pain Management Business (2018-2023)
11.7.5 Nobel Biocare Holdings Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Detail
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Lumbosacral Radicular Pain Management Introduction
11.8.4 Eli Lilly and Company Revenue in Lumbosacral Radicular Pain Management Business (2018-2023)
11.8.5 Eli Lilly and Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
